Effect of Non Surgical Treatment of Periodontitis on Diabetes Control

NCT02745015 — Not applicable, Completed, 45 participants, Yaounde Central Hospital

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Effect of Non Surgical Treatment of Periodontitis on Glycaemic Control in a Type 2 Diabetic Populations of Cameroon

RegistryNCT02745015, acronym PARODIA1
StatusCompleted
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: single, treatment
Enrollment45 (Actual)
SponsorYaounde Central Hospital (Other gov)
ConditionsPeriodontitis, Diabetes
Interventionsnon-surgical periodontal treatment (Procedure)
Datesstart 2014-12-01, primary completion 2015-05-01, completion 2015-05-01, first posted 2016-04-20, last updated 2016-07-19
Locations1 site in Cameroon

Related Papers Related Patents Related Grants Related Experts
All trials for Periodontitis All trials for Diabetes All trials of non-surgical periodontal treatment

-Summary

The aim of this study is to investigate the effects of non-surgical periodontal treatment on the metabolic control of type2 diabetes patients. Patients with type two diabetes mellitus patients and confirmed chronic periodontitis will be selected and randomly assign to two groups. The treatment group will receive immediate full-mouth scaling and root planing whereas the control group will be scheduled to receive periodontal treatment at the following 3-month visit. Plaque index, bleeding index, probing pocket depth, recessions and cervical attachment loss will be recorded at baseline, at six weeks and at three months. Glycated haemoglobin (HbA1c) and C-reactive protein (CRP) will be analysed at baseline and three months following enrolment.

Expand all sections  ·  Collapse all

+Detailed description

The aim of this study is to investigate the effects of non-surgical periodontal treatment on the metabolic control of type2 diabetes patients. Patients with type two diabetes mellitus patients and confirmed chronic periodontitis will be selected and randomly assign to two groups. The treatment group will receive immediate full-mouth scaling and root planing whereas the control group will be scheduled to receive periodontal treatment at the following 3-month visit. Plaque index, bleeding index, probing pocket depth, recessions and cervical attachment loss will be recorded at baseline, at six weeks and at three months. Glycated haemoglobin (HbA1c) and C-reactive protein (CRP) will be analysed at baseline and three months following enrolment.

+Arms and interventions

ArmTypeInterventionsDescription
treatmentExperimentalProcedure: non-surgical periodontal treatmentimmediate non-surgical periodontal treatment
controlOtherProcedure: non-surgical periodontal treatmentnon-surgical periodontal treatment scheduled for the following 3-monthly visit
  • non-surgical periodontal treatment (Procedure): full-mouth scaling and root planing

+Outcome measures

Primary outcomes

  • Metabolic [3 months]: Change in HbA1c

Secondary outcomes

  • Inflammation [3 months]: change in CRP level between baseline and 3-month post intervention
  • Periodontal 1 [3 months]: Change in plaque index between baseline and 3-month post intervention
  • Periodontal 2 [3 months]: Change in bleeding index between baseline and 3-month post intervention
  • Periodontal 3 [3 months]: Change in pocket depth between baseline and 3-month post intervention

+Eligibility

Sex: All, ages: 20 Years to 70 Years

Inclusion Criteria:

* Type 2 diabetes for at least one year
* periodontitis
* HbA1c > 7%

Exclusion Criteria:

* Periodontal treatment in the last 6 months
* antibiotics in the last 3 months
* tobacco smoking
* pregnancy

+Locations (1)

FacilityCityCountryStatus
National Obesity CentreYaoundéCameroon

+Publications

  • Results publication: Tsobgny-Tsague NF, Lontchi-Yimagou E, Nana ARN, Tankeu AT, Katte JC, Dehayem MY, Bengondo CM, Sobngwi E. Effects of nonsurgical periodontal treatment on glycated haemoglobin on type 2 diabetes patients (PARODIA 1 study): a randomized controlled trial in a sub-Saharan Africa population. BMC Oral Health. 2018 Feb 26;18(1):28. doi: 10.1186/s12903-018-0479-5. PMID 29482543